Fujirebio (Belgium)

Fujirebio (Belgium)

Innogenetics N.V. was an international in vitro diagnostics company, with headquarters in Ghent, Belgium. Founded in 1985, the company developed and marketed IVD testing solutions as well as OEM raw materials. The company was acquired in September 2010 by Japanese Fujirebio Inc., an H.U. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Fujirebio (Belgium), Belgium, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

52%


Total
Publications

432


Total Open
Publications

226


Total
Citations

27K


Open Access
Percentage

52%


Total
Publications

432


Total Open
Publications

226


Total
Citations

27K

Wikipedia

Website

download

Breakdown

22% 17% 13% 48%

Publisher Open

22%

Both

17%

Other Platform Open

13%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

13%OA Journal

OA Journal 13%

22

Hybrid 13%

22

No Guarantees 74%

125

Other Platform Open

Domain 68%

89

Institution 44%

57

Other Internet 13%

17

Public 7%

9

Preprint 3%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
87
Europe PMC
Domain
71
University College London - UCL Discovery
Institution
19
Ghent University - Ghent University Academic Bibliography
Institution
14
DOI
Other Internet
11
Semantic Scholar
Public
9
CiteSeer X
Other Internet
8
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
6
Radboud University - Radboud Repository
Institution
5
University of Antwerp - Institutional Repository University of Antwerp
Institution
4
1 / 6

Data updated 13 May 2024

Share

Share

Share